Top compounds associated with response to RNF170


Feature Type Standardized
Nominal ANOVA
mRNA carboplatin:etoposide (40:17 mol/mol) CTRPv2 pan-cancer AAC -0.079 0.008
mRNA Teniposide CTRPv2 pan-cancer AAC -0.1 0.008
mRNA Rapamycin CTRPv2 pan-cancer AAC 0.09 0.009
mRNA RDEA119 GDSC1000 pan-cancer AAC 0.079 0.009
mRNA XL-184 GDSC1000 pan-cancer AAC 0.087 0.01
mRNA AZ628 GDSC1000 pan-cancer AAC 0.13 0.01
mRNA ISOX:bortezomib (250:1 mol/mol) CTRPv2 pan-cancer AAC -0.089 0.01
mRNA Bexarotene GDSC1000 pan-cancer AAC 0.091 0.01
mRNA Nutlin-3a (-) GDSC1000 pan-cancer AAC 0.086 0.01
mRNA etoposide CTRPv2 pan-cancer AAC -0.075 0.01
Download CSV